Continuous Manufacturing: Cost, Lack Of Know-How Have Deterred Generic Firms, Prof Says

Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.

Continuous Production on the Metal Gears on Black Background.
Hearing focuses on bill intended to expand use of continuous manufacturing

While brand name companies are adopting continuous manufacturing, others are struggling with the cost and knowledge required for implementation, Rutgers University professor Fernando Muzzio testified at a congressional hearing.

Speaking before the House Energy & Commerce Health Subcommittee on 24 January, Muzzio voiced support for H.R. 4866, the National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act. Introduced in October by E&C Committee Chairman Frank Pallone Jr., D-NJ, and Rep

More from Manufacturing

More from Compliance